The role of ROX and mROX indices in predicting intubation in COVID 19 patients treated with high flow nasal oxygen in Intensive Care Unit
<b>Aim:</b> In Coronavirus disease 2019 (COVID-19)-related respiratory failure, high-flow nasal oxygen (HFNO) therapy may delay invasive ventilation. The respiratory rate oxygenation (ROX) and modified ROX (mROX) indices, which can predict the need for invasive ventilation, can also be u...
Saved in:
Main Authors: | İlkay Ceylan (Author), Halil Erkan Sayan (Author), Korgün Ökmen (Author), Umut Öylevi (Author) |
---|---|
Format: | Book |
Published: |
National Scientific Medical Center,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pulse dose glucocorticosteroid therapy in COVID-19 pneumonia patients in an intensive care unit
by: İlkay Ceylan, et al.
Published: (2022) -
Virtual Screening of Potential RoxS Inhibitors and Evaluation of Their Antimicrobial Activity in Combination with Antibiotics against Clinically Resistant Bacteria
by: Ya-Yan Huang, et al.
Published: (2023) -
The effect of therapeutic plasma exchange and intravenous immunoglobulin therapy on biomarkers and 28-day mortality in patients with COVID-19 in intensive care unit
by: Korgün Ökmen, et al.
Published: (2023) -
Comparison of the Efficacies of High-Flow Nasal Cannula Oxygen Therapy and Non-invasive Nasal Cannula Ventilation in Preventing Intubation
by: Ülkem Koçoğlu Barlas, et al.
Published: (2024) -
Analysis of predictors of response to high-flow oxygen nasal cannula therapy in a pediatric intensive care unit
by: Irene Baquedano-Lobera, et al.
Published: (2022)